Business Wire | May 20, 2021 08:00AM EDT

Incyte to Present at Upcoming Investor Conferences

May 20, 2021

WILMINGTON, Del.--(BUSINESS WIRE)--May 20, 2021--Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June:

* William Blair 41st Annual Growth Stock Conference (Virtual) on Thursday, June 3, 2021 at 1:00 pm (EDT) * BioPharma Sustainability Roundtable's CEO Investor Forum on Monday, June 7, 2021 at 1:35 pm (EDT) * Goldman Sachs 42nd Annual Global Healthcare Conference (Virtual) on Tuesday, June 8, 2021 at 8:00 am (EDT) * Guggenheim's "Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation" Series on Monday, June 28, 2021 at 11:00 am (EDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005078/en/

CONTACT: Incyte Media Catalina Loveman +1 302 498 6171 cloveman@incyte.com

CONTACT: Investors Christine Chiou +1 302 274 4773 cchiou@incyte.com